Answers are grounded in this paper and cite their sources.
Case highlights successful treatment of pulmonary aspergillosis and cryptococcosis in HIV coinfection, suggesting novel treatment options.
The case highlights the need to consider aspergillosis in patients with cryptococcal infections and unexplained respiratory symptoms, as well as in smear‐negative pulmonary tuberculosis. When standard triazoles are unavailable, novel oral amphotericin B (MAT2203) successfully treated both invasive pulmonary aspergillosis and cryptococcosis in this case of coinfection, warranting further evaluation.
No takes yet. Share an insight, caveat, or question.
Kagimu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: